Reducing Hypoglycemia Fear in Parents of Young Children With Type 1 Diabetes

University of Kansas Medical Center43 enrolled

Overview

Pilot of a novel video-based telemedicine intervention to reduce fear of hypoglycemia in parents of young children with type 1 diabetes.

This was a two group randomized controlled study using a wait-list control design. All participating parents had the opportunity to receive 10 video-based telemedicine sessions administered over 13 weeks. Study assessments took place at baseline, post-treatment, and 3 month followup. Study outcomes included parent reported hypoglycemia fear, parenting stress, diabetes distress, and child glycated hemoglobin.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

NONE

Enrollment

Conditions

Parents

Interventions

REDCHiPBEHAVIORAL

10 week video-based telemedicine intervention to reduce hypoglycemia fear

Eligibility

Sex: ALLMin age: 1 YearMax age: 6 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Parents of children, between 1-6 years old, with type 1 diabetes for at least 6 months, on either multiple daily injections or an insulin pump, and parents speak English Exclusion Criteria: * Families of children who are older than 6 years-old and or do not have type 1 diabetes; children follow a conventional insulin regimen

Outcomes

Primary Outcomes

Hypoglycemia Fear Survey

Hypoglycemia Fear Survey-Parents of Young Children. This is a measure of parents' perceived hypoglycemia fear. Higher scores suggest greater fear (worse outcome). Total possible range: 26-130.

Time frame: absolute value at post-treatment (week 14)

Secondary Outcomes

Child Hemoglobin A1c

Child hemoglobin A1c- biological marker of glycemic control

Time frame: absolute value at post-treatment (week 14)

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.